Literature DB >> 14975125

Localization of genes involved in the metabolic syndrome using multivariate linkage analysis.

Curtis Olswold1, Mariza de Andrade.   

Abstract

There are no well accepted criteria for the diagnosis of the metabolic syndrome. However, the metabolic syndrome is identified clinically by the presence of three or more of these five variables: larger waist circumference, higher triglyceride levels, lower HDL-cholesterol concentrations, hypertension, and impaired fasting glucose. We use sets of two or three variables, which are available in the Framingham Heart Study data set, to localize genes responsible for this syndrome using multivariate quantitative linkage analysis. This analysis demonstrates the applicability of using multivariate linkage analysis and how its use increases the power to detect linkage when genes are involved in the same disease mechanism.

Entities:  

Mesh:

Year:  2003        PMID: 14975125      PMCID: PMC1866494          DOI: 10.1186/1471-2156-4-S1-S57

Source DB:  PubMed          Journal:  BMC Genet        ISSN: 1471-2156            Impact factor:   2.797


Background

It has been shown that for correlated traits, multivariate approaches for genetic linkage analyses can increase the power and precision to identify genetic effects [1-4]. When correlated measures are considered, the composite score from joint consideration of all measures reflects a smaller level of measurement error than each of the univariate measures [5]. Then, multivariate analysis provides a statistically efficient mechanism for controlling the analysis-wise significance level when there are multiple trait observations for each subject [3,6]. Therefore, using methods that can analyze several traits jointly is likely to enhance the ability to identify genes influencing the metabolic syndrome. Although multivariate Haseman-Elston (H-E) [7] and variance-components (VC) methods [8] have been available for several years, only recently has the power of these methods been compared. Allison et al. [6] presented results from a large simulation study to assess the effectiveness of a bivariate H-E test for linkage versus the univariate H-E test [9]. Their results showed that bivariate analyses can improve the power to detect linkage, with a greater gain in power when the genetic covariance due to a major locus linked to the marker studied is negative and the residual covariance among the traits is positive. Amos et al. [3] also showed that bivariate approaches are more powerful than univariate analyses except for traits with very high positive polygenic correlation. Evans [4] also reached similar conclusion. Our approach is based on the assumption that it is easier to detect a quantitative trait locus (QTL) involved in the metabolic syndrome using multivariate linkage analysis. Our aim is to show that using combinations of traits related to the metabolic syndrome, and then using them in multivariate linkage analysis software, gives reliable results for linkage to genes associated with this syndrome.

Methods

The metabolic syndrome

There are no well accepted criteria for the diagnosis of the metabolic syndrome. However, the metabolic syndrome is identified by the presence of three or more of the variables listed in Table 1[10].
Table 1

Clinical identification of the metabolic syndrome

Risk FactorDefining Level
Abdominal ObesityWaist Circumference
 Men> 102 cm (> 40 in)
 Women> 88 cm (> 35 in)
Triglycerides= 150 mg/dL
HDL cholesterol
 Men< 40 mg/dL
 Women< 50 mg/dL
Blood Pressure= 130/85 mm Hg
Fasting Glucose110–125 mg/dL

Multivariate linkage analysis

The multivariate variance-components (MVC) approach is an extension of the univariate approach described by Amos [8]. For multivariate traits, let Y= (Y11,...,Y1,...,Y)' be a vector of m multivariate trait values for kmembers of the ith family. Let N be the total number of families, β a vector of dimension mp of the regression coefficients for the p covariates (including a vector of 1's corresponding to the overall mean), X= IXan mk× mp known matrix of covariate values for the ith family, where is the Kronecker product, and Va VC matrix of dimension mk× mk. Then, the variance-covariance matrix of the traits is VGZI, where Gis the k× kmatrix of the coefficients of relationship for the family i; Zan k× kmatrix of estimated proportion of alleles identical by decent (IBD) for pairs of related individuals for the ith pedigree; Iis the k× kidentity matrix; and A, B, and C, are, respectively, polygenic, major-gene, and environment variance-covariance matrices each of dimension m × m. A more detailed description of these models was presented elsewhere [11,12].

Multivariate VC test

To test for genetic linkage, we also construct a likelihood ratio test. Under the null hypothesis, the major gene parameter(s) are restricted to equal 0. The distribution of the multivariate test is a mixture of χ2 values [13]. For trivariate linkage analysis of an additive genetic effect, the distribution of the trivariate test that the major-gene covariance components are zero is a mixture of 1/8 χ02, 3/8 χ12, 3/8 χ32 and 1/8 χ62. One-eighth of the time all the VCs are estimated to be positive with all the covariances different from 0 yielding 6 degrees of freedom. Three-eighths of the time, one of the VCs is estimated to be zero with two covariances fixed to zero (yielding 3 degrees of freedom). Another three-eighths of the time two VCs are fixed to zero with all covariances equal to zero yielding 1 degree of freedom. Finally, one-eighth of the time all the variances are fixed to zero resulting in a degenerate distribution of point mass at zero. For the multivariate linkage analysis, we use the following four traits: triglycerides, HDL-cholesterol, systolic blood pressure (SBP), and fasting glucose. Since these variables, except for triglycerides, were measured at several time points, we applied a similar regression approach described in Levy et al. [14] for these four variables and then used their residuals as the quantitative traits in the multivariate genome-wide linkage analysis for quantitative traits. There are two packages that use the MVC approach: ACT [15] and EMVC [16]. The analyses here presented were performed using the EMVC package using 330 families with 4692 individuals, of whom 1702 have genotype information.

Results

We do observe small to moderate positive genetic correlations between SBP and triglycerides (0.187), SBP and fasting glucose (0.296), and triglycerides and fasting glucose (0.361); we also observe a strong negative correlation between HDL-cholesterol and triglycerides (-0.664), and small to moderate negative correlations between HDL-cholesterol and SBP (-0.048), and HDL-cholesterol and fasting glucose (-0.249). Table 2 shows the pair-wise polygenic and the quantitative trait locus (qtl) correlation among the four traits at the position where evidence for linkage was found for the trivariate linkage analysis. We observed moderate to strong polygenic and qtl correlation for all traits except for polygenic correlation for SBP and fasting glucose SBP and HDL-cholesterol on chromosome 6 at 152 cM.
Table 2

Values of polygenic and QTL correlation between the variables involved in the metabolic syndrome at different locations

QTL Effects for TraitsPolygenic Effects for Traits

TraitsA (1, 2, 3)ChrPos (cM)LOD1 and 2B1 and 32 and 31 and 2C1 and 32 and 3
S,G,T21365.370.409-0.620.3420.620.4040.873
H,G,T21404.97-0.81-0.830.573-0.18-0.640.858
S,H,G2384.420.5570.25-0.21-0.540.565-0.53
S,H,T2383.700.637-0.32-0.19-0.570.592-0.82
S,G,T5305.240.3170.0960.9540.1220.525-0.58
H,G,T51863.810.0780.6830.122-0.7-0.970.802
S,H,G5302.800.6020.1380.235-0.270.721-0.59
S,H,T5343.35-0.14-0.150.149-0.060.643-0.74
S,G,T61525.490.0840.4050.7990.320.2890.69
H,G,T61525.30-0.03-0.890.365-0.27-0.840.59
S,H,T61525.18-0.370.33-0.910.0030.19-0.87
S,G,T17103.020.477-0.330.3080.3310.7270.44
S,H,T17123.910.694-0.34-0.08-0.350.622-0.90

AS, systolic blood pressure; G, fasting glucose; T, triglycerides; H, HDL-cholesterol.

Figure 1 depicts the trivariate multipoint linkage analyses results of chromosomes 2, 5, 6, and 17. Because of space constraints we show only the trivariate results. The trivariate lod scores were obtained using EMVC program [16]. On chromosome 2, the following combination produced evidence for linkage: SBP, fasting glucose, and triglycerides (LOD 5.37, position 136 cM, P = 5.4 × 10-5); HDL, fasting glucose, and triglycerides (LOD 4.97, position 140 cM, P = 1.7 × 10-4); SBP, HDL, and fasting glucose (LOD 4.42, position 38 cM, P = 5 × 10-4); SBP, HDL, and triglycerides (LOD 3.70, position 38 cM, P = 1.5 × 10-3). The univariate maximum LOD scores for SBP, triglycerides, fasting glucose, and HDL were, respectively, 1.5 (34 cM), 1.75 (74 cM), 3.3 (136 cM), and 1.2 (38 cM). On chromosome 5, the following combination produced evidence for linkage: SBP, fasting glucose, and triglycerides (LOD 5.24, position 30 cM, P = 7 × 10-5); HDL, fasting glucose, and triglycerides (LOD 3.81, position 186 cM, P = 1.2 × 10-3); SBP, HDL, and triglycerides (LOD 3.35, position 34 cM, P = 2.8 × 10-3); SBP, HDL, and fasting glucose (LOD 2.80, position 30 cM, P = 7.9 × 10-3). The univariate maximum LOD scores for SBP, triglycerides, fasting glucose, and HDL were, respectively, 2.21 (34 cM), 1.97 (0 cM), 1.53 (160 cM), and 0.16 (160 cM). On chromosome 6, the following combination produced evidence for linkage: SBP, fasting glucose, and triglycerides (LOD 5.49, position 152 cM, P = 5 × 10-5); HDL, fasting glucose, and triglycerides (LOD 5.30, position 152 cM, P = 6 × 10-5); SBP, HDL, and triglycerides (LOD 5.18, position 152 cM, P = 1 × 10-4). The univariate maximum LOD scores for SBP, triglycerides, fasting glucose, and HDL were, respectively, 0.12 (2 cM), 5.52 (152 cM), 0.64 (44 cM), and 0.25 (182 cM). On chromosome 17, the following combination produced evidence for linkage: SBP, fasting glucose, and triglycerides (LOD 3.02, position 10 cM, P = 5.2 × 10-3); SBP, HDL, and triglycerides (LOD 3.91, position 12 cM, P = 1.2 × 10-3). The univariate maximum LOD scores for SBP, triglycerides, fasting glucose, and HDL were, respectively, 1.35 (66 cM), 1.76 (6 cM), 0 (-), and 0.22 (126 cM).
Figure 1

Comparison of LOD profiles for trivariate multipoint linkage analyses on chromosomes 2, 5, 6, and 17 The black line represents the trivariate traits SBP, glucose, and triglycerides. The red dot line represents the trivariate traits HDL, glucose, and triglycerides. The green line represents the trivariate traits SBP, HDL, and glucose. The blue line represent the trivariate traits SBP, HDL, and triglycerides.

Discussion

The MVC approach appears to perform well in the identification of regions linked to genes associated with traits related to the metabolic syndrome, mainly on regions where the QTL effects were negatively correlated and there was a positively correlated polygenic effect as shown by Amos et al. [3] and Evans [4]. Our results did identify a minor linkage peak to the same region of chromosome 17 described by Levy et al. [14]. The only region on chromosome 17 using the trivariate VC approach that showed evidence for linkage was on the surrounding region of 10 cM, which was due primarily to the bivariate combination, SBP and triglycerides, (LOD 3.14, position 12 cM, results not shown). Furthermore, evidence for linkage was also found on chromosomes 2, 5, and 6. We also showed that the pair-wise combinations with evidence for linkage are the ones that have either small to moderate genetic correlation or negative genetic correlation. In summary, the use of multivariate quantitative trait loci linkage analysis can increase the power to detect a QTL. However, this procedure is computationally intensive, i.e., the CPU time increases exponentially as the number of traits increases additively.
  14 in total

1.  Comparison of multivariate tests for genetic linkage.

Authors:  C Amos; M de Andrade; D Zhu
Journal:  Hum Hered       Date:  2001       Impact factor: 0.444

2.  An EM algorithm for obtaining maximum likelihood estimates in the multi-phenotype variance components linkage model.

Authors:  S J Iturria; J Blangero
Journal:  Ann Hum Genet       Date:  2000-07       Impact factor: 1.670

3.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

Authors: 
Journal:  JAMA       Date:  2001-05-16       Impact factor: 56.272

4.  The power of multivariate quantitative-trait loci linkage analysis is influenced by the correlation between variables.

Authors:  David M Evans
Journal:  Am J Hum Genet       Date:  2002-06       Impact factor: 11.025

5.  Increase in power through multivariate analyses.

Authors:  S Schmitz; S S Cherny; D W Fulker
Journal:  Behav Genet       Date:  1998-09       Impact factor: 2.805

Review 6.  A twin-pronged attack on complex traits.

Authors:  N Martin; D Boomsma; G Machin
Journal:  Nat Genet       Date:  1997-12       Impact factor: 38.330

7.  Assessing linkage on chromosome 5 using components of variance approach: univariate versus multivariate.

Authors:  M de Andrade; T J Thiel; L Yu; C I Amos
Journal:  Genet Epidemiol       Date:  1997       Impact factor: 2.135

8.  Robust variance-components approach for assessing genetic linkage in pedigrees.

Authors:  C I Amos
Journal:  Am J Hum Genet       Date:  1994-03       Impact factor: 11.025

9.  The investigation of linkage between a quantitative trait and a marker locus.

Authors:  J K Haseman; R C Elston
Journal:  Behav Genet       Date:  1972-03       Impact factor: 2.805

10.  Evidence for a gene influencing blood pressure on chromosome 17. Genome scan linkage results for longitudinal blood pressure phenotypes in subjects from the framingham heart study.

Authors:  D Levy; A L DeStefano; M G Larson; C J O'Donnell; R P Lifton; H Gavras; L A Cupples; R H Myers
Journal:  Hypertension       Date:  2000-10       Impact factor: 10.190

View more
  4 in total

1.  Robust estimation of experimentwise P values applied to a genome scan of multiple asthma traits identifies a new region of significant linkage on chromosome 20q13.

Authors:  Manuel A R Ferreira; Louise O'Gorman; Peter Le Souëf; Paul R Burton; Brett G Toelle; Colin F Robertson; Peter M Visscher; Nicholas G Martin; David L Duffy
Journal:  Am J Hum Genet       Date:  2005-10-14       Impact factor: 11.025

Review 2.  Genetic determinants of the metabolic syndrome.

Authors:  Michèle M Sale; Jonathan Woods; Barry I Freedman
Journal:  Curr Hypertens Rep       Date:  2006-04       Impact factor: 5.369

3.  Quantitative trait locus mapping of genetic modifiers of metabolic syndrome and atherosclerosis in low-density lipoprotein receptor-deficient mice: identification of a locus for metabolic syndrome and increased atherosclerosis on chromosome 4.

Authors:  Sara Bretschger Seidelmann; Carl De Luca; Rudolph L Leibel; Jan L Breslow; Alan R Tall; Carrie L Welch
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-10-28       Impact factor: 8.311

4.  Heritabilities of the metabolic syndrome and its components in the Northern Manhattan Family Study.

Authors:  H-F Lin; B Boden-Albala; S H Juo; N Park; T Rundek; R L Sacco
Journal:  Diabetologia       Date:  2005-08-04       Impact factor: 10.122

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.